AU4135600A - Prostate cancer associated human fibronectin gene and biallelic markers - Google Patents
Prostate cancer associated human fibronectin gene and biallelic markersInfo
- Publication number
- AU4135600A AU4135600A AU41356/00A AU4135600A AU4135600A AU 4135600 A AU4135600 A AU 4135600A AU 41356/00 A AU41356/00 A AU 41356/00A AU 4135600 A AU4135600 A AU 4135600A AU 4135600 A AU4135600 A AU 4135600A
- Authority
- AU
- Australia
- Prior art keywords
- prostate cancer
- cancer associated
- biallelic markers
- human fibronectin
- associated human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12678099P | 1999-03-29 | 1999-03-29 | |
US60126780 | 1999-03-29 | ||
PCT/IB2000/000431 WO2000058509A2 (en) | 1999-03-29 | 2000-03-28 | Prostate cancer associated human fibronectin gene and biallelic markers |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4135600A true AU4135600A (en) | 2000-10-16 |
Family
ID=22426617
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU41356/00A Abandoned AU4135600A (en) | 1999-03-29 | 2000-03-28 | Prostate cancer associated human fibronectin gene and biallelic markers |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU4135600A (en) |
WO (1) | WO2000058509A2 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008046510A1 (en) * | 2006-10-16 | 2008-04-24 | Bayer Healthcare Ag | Fn1 as a biomarker, therapeutic and diagnostic target |
KR101251538B1 (en) | 2009-04-17 | 2013-04-08 | (주)아벨리노 | Primer for Avellino Corneal Dystrophy |
KR101125212B1 (en) | 2010-10-01 | 2012-03-21 | (주)아벨리노 | System for diagnosis of avellino corneal dystrophy |
US10889850B2 (en) | 2013-03-15 | 2021-01-12 | Avellino Lab Usa, Inc. | Methods for improved isolation of genomic DNA templates for allele detection |
KR20210037750A (en) * | 2013-03-15 | 2021-04-06 | 아벨리노 랩 유에스에이, 인크. | Methods for improved isolation of genomic dna templates for allele detection |
AU2014348279B2 (en) | 2013-11-15 | 2021-02-18 | Avellino Lab Usa, Inc. | Methods for multiplex detection of alleles associated with ophthalmic conditions |
EP4036228A1 (en) | 2015-11-13 | 2022-08-03 | Avellino Lab USA, Inc. | Methods for the treatment of corneal dystrophies |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5578444A (en) * | 1991-06-27 | 1996-11-26 | Genelabs Technologies, Inc. | Sequence-directed DNA-binding molecules compositions and methods |
EP0892068A1 (en) * | 1997-07-18 | 1999-01-20 | Genset Sa | Method for generating a high density linkage disequilibrium-based map of the human genome |
-
2000
- 2000-03-28 WO PCT/IB2000/000431 patent/WO2000058509A2/en active Application Filing
- 2000-03-28 AU AU41356/00A patent/AU4135600A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2000058509A3 (en) | 2002-09-12 |
WO2000058509A2 (en) | 2000-10-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3619400A (en) | Human prostate cancer associated gene sequences and polypeptides | |
AU2001278070A1 (en) | Basal cell markers in breast cancer and uses thereof | |
AU3316600A (en) | Gene expression in bladder tumors | |
AU8026600A (en) | Brachytherapy instrument and methods | |
AUPQ923100A0 (en) | Treatment of prostate cancer | |
AU2002360345A1 (en) | Prostate cancer genes | |
AU2003224598A1 (en) | Differentially-regulated prostate cancer genes | |
AU2002356898A1 (en) | Gene amplification and overexpression in cancer | |
AU3072500A (en) | Rhamnosyl-transferase gene and uses thereof | |
AU4009899A (en) | Molecules targeting cd40 and tumor cells | |
AU4135600A (en) | Prostate cancer associated human fibronectin gene and biallelic markers | |
AU2238499A (en) | Androgen-metabolic gene mutations and prostate cancer risk | |
AU8026300A (en) | Sodd gene expression in cancer | |
AU2001226922A1 (en) | Cancer associated genes and their products | |
AU6111800A (en) | 26 human prostate and prostate cancer associated proteins | |
EP1208232A4 (en) | Markers for prostate cancer | |
GB9828840D0 (en) | Prostate cancer associated genes and their products | |
AU2041901A (en) | Genes essential for microbial proliferation and antisense thereto | |
AU2002243300A1 (en) | Human genes and gene expression products isolated from human prostate | |
AU1894601A (en) | Novel gene and use thereof | |
GB0025890D0 (en) | Gene therapy | |
AU7064500A (en) | Human narcolepsy gene | |
AU5416700A (en) | Differentially expressed genes in prostate cancer | |
AU4860299A (en) | (zap-3) tumor associated genes and their uses | |
AU2001288940A1 (en) | Gene and sequence variation associated with cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |